Time course investigation of PPARalpha- and Kupffer cell-dependent effects of WY-14,643 in mouse liver using microarray gene expression (scientific article)

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

Q24652367

GoMiner: a resource for biological interpretation of genomic and proteomic data

Q24796534

High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID).

Q24815153

DAVID: Database for Annotation, Visualization, and Integrated Discovery

Q27499374

Missing value estimation methods for DNA microarrays

Q28200763

The p47phox mouse knock-out model of chronic granulomatous disease

Q28504676

Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators

Q28512252

Tumor necrosis factor alpha is not required for WY14,643-induced cell proliferation

Q32128574

Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes

Q32129114

Role of cytokines in non-genotoxic hepatocarcinogenesis: cause or effect?

Q34232437

Cytokines in the liver

Q34320108

Mimetics of caloric restriction include agonists of lipid-activated nuclear receptors

Q34339895

Complement and apoptosis

Q34353040

PPARalpha agonist-induced rodent tumors: modes of action and human relevance

Q35631058

Sustained formation of alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone radical adducts in mouse liver by peroxisome proliferators is dependent upon peroxisome proliferator-activated receptor-alpha, but not NADPH oxidase

Q35691236

Innate immunity in the liver

Q36036373

Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand?

Q36174039

Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.

Q36586072

The clearance of apoptotic cells by complement

Q36838417

Hepatocellular proliferation in response to a peroxisome proliferator does not require TNFalpha signaling

Q38294966

Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver.

Q38336592

Gene ontology mapping as an unbiased method for identifying molecular pathways and processes affected by toxicant exposure: application to acute effects caused by the rodent non-genotoxic carcinogen diethylhexylphthalate

Q38520410

Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro

Q40835154

Peroxisome proliferators activate Kupffer cells in vivo

Q42513524

The PPARalpha-leukotriene B4 pathway to inflammation control.

Q42552721

Phthalates rapidly increase production of reactive oxygen species in vivo: role of Kupffer cells

Q43548374

The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism.

Q43726411

Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis

Q43838034

The membrane attack complex of complement induces caspase activation and apoptosis

Q43900091

Impaired Ras membrane association and activation in PPARalpha knockout mice after partial hepatectomy

Q44185466

Gene expression changes induced in mouse liver by di(2-ethylhexyl) phthalate

Q44260004

Protein expression changes in the Sprague Dawley rat liver proteome following administration of peroxisome proliferator activated receptor alpha and gamma ligands

Q44398410

Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators

Q44761807

The transcriptional response to a peroxisome proliferator-activated receptor alpha agonist includes increased expression of proteome maintenance genes

Q45064169

Peroxisome proliferator-activated receptor alpha induces NADPH oxidase activity in macrophages, leading to the generation of LDL with PPAR-alpha activation properties

Q45148001

Peroxisome proliferator activated receptor-alpha expression in human liver.

Q46493867

WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase.

Q51010973

EDGE: extraction and analysis of differential gene expression.

Q51958109

In vivo hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway.

Q52531947

Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis.

Q53411525

Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARalpha and TNFalpha.

Q53412221

Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643.

Q53439121

Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet.

Q53572901

Effects of peroxisome proliferators on the thymus and spleen of mice

Q73223344

Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643

Q73248678

In vitro knockout of human p47phox blocks superoxide anion production and LDL oxidation by activated human monocytes

Q73520352

Gene expression analysis reveals chemical-specific profiles

Q74100166

Pathway studio—the analysis and navigation of molecular networks

Q79241603

P433

issue

P304

page(s)

267-277

P577

publication date

2007-09-16

P1433

published in

Toxicology and Applied Pharmacology

Q2446974

P1476

title

Time course investigation of PPARalpha- and Kupffer cell-dependent effects of WY-14,643 in mouse liver using microarray gene expression

P478

volume

225

Reverse relations

cites work (P2860)

Q35138153	A Comparative Study of Mouse Hepatic and Intestinal Gene Expression Profiles under PPARα Knockout by Gene Set Enrichment Analysis
Q37478119	Characterization of peroxisome proliferator-activated receptor alpha--independent effects of PPARalpha activators in the rodent liver: di-(2-ethylhexyl) phthalate also activates the constitutive-activated receptor
Q42540572	Computational toxicology: realizing the promise of the toxicity testing in the 21st century
Q57016009	Genes involved in the induction of liver growth by peroxisome proliferators
Q33870766	Inflammatory mediators and insulin resistance in obesity: role of nuclear receptor signaling in macrophages
Q34006474	Integrating transcriptomics and metabonomics to unravel modes-of-action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in HepG2 cells
Q38158164	Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study.
Q42709872	Perfluorooctanoic acid induced-developmental cardiotoxicity: are peroxisome proliferator activated receptor α (PPARα) and bone morphorgenic protein 2 (BMP2) pathways involved?
Q35210023	Peroxisome proliferator-activated receptors and cancer: challenges and opportunities
Q46249387	The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions.
Q37125240	Time-course comparison of xenobiotic activators of CAR and PPARalpha in mouse liver
Q35633882	Toxicogenomic biomarkers for liver toxicity